BRIEF: Qyuns Therapeutics secures CSRC approval for full H-share circulation
Biopharmaceutical company Qyuns Therapeutics Co. Ltd. (2509.HK) announced on Tuesday that the China Securities Regulatory Commission (CSRC) has approved its plan to convert 17.32 million of its domestic shares into…
Recent Articles
RELATED ARTICLES
-
BRIEF: Rimag Group secures CSRC approval for full circulation of H-Shares
2522.HK
- BRIEF: Bloks Group secures CSRC approval for Hong Kong IPO
-
BRIEF: Surging Laopu Gold to boost share float after full circulation approval
6181.HK
- BRIEF: Coland Ocean secures CSRC approval for Hong Kong IPO
- BRIEF: Green Tea Group secures CSRC approval for Hong Kong IPO
-
BRIEF: Voicecomm approved for full H-share circulation
2495.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
